Triglyceride glucose index is associated with obstructive coronary artery disease in hypertensive patients

Weili Pan1, Yongkui Ren1, Fan Yang2

  • 1Department of Cardiology, the First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.

Insights

The triglyceride glucose (TyG) index is linked to a higher risk of obstructive coronary artery disease (OCAD) in patients with hypertension. Higher TyG index values indicate an increased likelihood of developing OCAD.

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Syndrome

Background:

  • Hypertension is a primary risk factor for coronary artery disease (CAD).
  • The triglyceride glucose (TyG) index serves as a marker for insulin resistance (IR).
  • Limited research exists on the association between the TyG index and the incidence of obstructive CAD (OCAD) in hypertensive individuals.

Purpose of the Study:

  • To investigate the relationship between the TyG index and the incidence of OCAD in hypertensive patients.
  • To determine if the TyG index can predict the development of OCAD in this population.

Main Methods:

  • A retrospective study involving 1841 hypertensive patients without prior CAD history.
  • Coronary computed tomography angiography (CCTA) was used to diagnose OCAD (stenosis ≥50%).
  • The TyG index was calculated using fasting triglycerides and glucose levels.

Main Results:

  • 310 patients (16.8%) developed OCAD.
  • A J-shaped relationship was observed between TyG index and OCAD incidence.
  • Elevated TyG index tertiles (T2 and T3) were significantly associated with increased OCAD risk compared to the lowest tertile (T1).
  • A 1-SD increase in TyG index raised OCAD risk by 49%.

Conclusions:

  • The TyG index is significantly associated with the incidence of obstructive CAD in hypertensive patients.
  • The TyG index may serve as a valuable predictive marker for OCAD in hypertensive individuals.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
46
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
36
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
19
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
23
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
22